The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Treating Patients With Stage IV Lung Adenocarcinoma Without Actionable Oncogenic Drivers

H. Jack West, MD
Published Online: 8:55 PM, Fri November 10, 2017

H. Jack West, MD, a thoracic oncologist of Swedish Cancer Institute at Swedish Medical Center, discusses appropriate treatment for patients with stage IV adenocarcinoma who do not harbor oncogenic drivers.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.